Welltica+ reports the drug could prevent about 70% of the muscle loss people usually see while taking Ozempic and similar drugs.
Recap by typeshit. Full story at Welltica+ on MSN.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
A short Philstar Life item on PIONEER 8, a trial of oral semaglutide. The material gives only the title, so tap through for the details.
Wellness experts are giving fasting fresh attention while GLP-1 drugs make eating more complicated, especially for women.
The review covers how GLP-1 drugs touch metabolic, inflammatory and nerve survival pathways tied to Parkinson's. Protective effects so far come from lab and animal models.
Loading…